Infectious diseases
Physician practices and perceived barriers concerning adult vaccination of patients with Medicare versus commercial insurance
McNamara M, Buck P, Yan S, Friedland LR, Lerch K, Murphy A, Turner-Bowker DM, Taylor F, Lamoureux R, Klooster B, Hogea C
Presented at the 48th National Immunization Conference, Atlanta, GA, 15-18 May 2018
Simeprevir added to peginterferon and ribavirin lessens time with fatigue, depressive symptoms and functional limitations in patients with chronic hepatitis C compared with peginterferon and ribavirin: results from 1161 patients in the QUEST-1, QUEST-2 and PROMISE studies
Scott J, Gilles L, Fu M, Brohan E, Panter C, Arbuckle R, Jessner W, Beumont M
J Viral Hepat 2015;22(8):639-50
The humanistic, economic and societal burden of herpes zoster in Europe: A critical review
Gater A, Uhart M, McCool R, Préaud E
BMC Public Health 2015, 15:193
Understanding disease presentation and patient-reported and economic impact of herpes zoster and post-herpetic neuralgia: Findings from the zoster quality of life study
Carroll S, Gater A, Abetz L, Demuth D, Smith F, Mannan A
Value Health;15:A514
Burden of herpes zoster in the UK: Findings from the Zoster Quality of Life (ZQOL) study
Gater A, Abetz-Webb L, Carroll S, Mannan A, Serpell M, Johnson R
BMC Infect Dis. 2014 Jul 20;14:402
Burden of post-herpetic neuralgia in a sample of UK residents aged 50 years or older: Findings from the Zoster Quality of Life (ZQOL) study
Serpell M, Gater A, Carroll S, Abetz-Webb L, Mannan A, Johnson R
Health Qual Life Outcomes. 2014 Jun 11;12:92
Real world studies using Japanese administrative databases: Chronic hepatitis C treatment pattern and resource use
Crawford B, Tang A, Li H, Burns L, Wada K, McDonald J
Poster session presented at: International Society for Pharmacoeconomics and Outcomes Research (ISPOR), 17th Annual European Congress, Amsterdam, Netherlands, 8-12 November 2014
The secondary care cost burden to the NHS associated with the 2012 pertussis outbreak in England
Holbrook T, Coles V, Carroll S, Pollard C, Oakley S
Poster session presented at: 32nd Annual Meeting of the European Society for Paediatric Infectious Diseases, Dublin, Ireland, May 6-10 2014
Challenges in quantifying the patient-reported burden of herpes zoster and post-herpetic neuralgia in the UK: Learnings from the Zoster Quality of Life (ZQOL) study
Carroll S, Gater A, Abetz-Webb L, Smith F, Demuth D, Mannan A
BMC Research Notes 2013, Nov 25;6:486
Fatigue severity scale: Reliability, validity and interpretation of change – evidence from two clinical trials in patients with chronic HCV infection
Scott J, Rosa K, Fu M, Cerri K, Peeters M, Beumont-Mauviel M, Gilles L, Blackburn S
Poster session presented at: International Society for Pharmacoeconomics and Outcomes Research (ISPOR), 18th International Meeting, New Orleans, USA, 20 -22 May 2013
Herpes zoster in Europe: A review of evidence documenting humanistic, economic and societal burden
McCool R, Gater A, Préaud E, Baron-Papillon F, Largeron N
Poster session presented at: International Society for Pharmacoeconomics and Outcomes Research (ISPOR), 16th Annual European Congress, Dublin, Ireland, 2-6 November 2013
Interviews with patients with chronic hepatitis C virus infection document unmet needs, content validity, and comprehension of PROs for clinical trials
Blackburn S, McCool R, Panter C, Young V, Peterson S, Mitchell L, Machouf N, Scott J, Humphrey L
Poster session presented at: International Society for Pharmacoeconomics and Outcomes Research (ISPOR), 18th International Meeting, New Orleans, USA, 20 -22 May 2013
Patients with chronic hepatitis C virus treated with simeprevir added to peginterferon and ribavirin experienced less time with fatigue, depressive symptoms, and functional limitations: results from patients in the quest-1, quest-2, and promise studies
Scott J, Gilles L, Fu M, Brohan E, Amatya R, Jessner W, Beumont-Mauviel
Poster session presented at: International Society for Pharmacoeconomics and Outcomes Research (ISPOR), 16th Annual European Congress, Dublin, Ireland, 2-6 November 2013
Hepatitis C in Asia: Prevalence and complications
Crawford B, Tanaka E, Yeung CK, Hwang S, Leteneux C, Kraemer M, Wang YJ, Chanatitarat C
Poster session presented at: Asian Pacific Association for the Study of the Liver conference, Taipei, Taiwan, 17–19 February 2012
Hepatitis C virus in Asia: Utility values based on the Short Form-36 Questionnaire (SF-36)
Crawford B, Yeung CK, Tanaka E, Kraemer M, Leteneux C
Expert Review of Pharmacoeconomics and Outcomes Research 2012;12:765-773
Interviews with patients with chronic hepatitis C (CHC) virus infection document unmet needs, content validity, and comprehension of PROs for clinical trials
Blackburn S, McCool R, Panter C, Young V, Peterson S, Mitchell L, Machouf N, Scott J, Humphrey L
Poster session presented at: International Society for Pharmacoeconomics and Outcomes Research (ISPOR), 17th Annual International Meeting, Washington, USA, 2-6 June 2012
Understanding disease presentation and patient-reported and economic impact of herpes zoster and post-herpetic neuralgia: findings from the zoster quality of life study
Carroll S, Gater A, Abetz L, Demuth D, Smith F, Mannan A
Poster presented at the 15th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Berlin, Germany, 2012
Burden of herpes zoster and post-herpetic neuralgia: Findings from a cross-sectional patient reported outcomes study
Carroll S, Gater A, Abetz L, Demuth D, Smith F, Mannan A
Poster presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Madrid, Spain, 2011
Burden of herpes zoster and post-herpetic neuralgia: Findings from a cross-sectional patient-reported outcomes study
Carroll S, Gater A, Abetz L, Demuth D, Smith F, Mannan A
Value Health 2011;14:A405
Burden of herpes zoster and post-herpetic neuralgia: Findings from a cross-sectional patient-reported outcomes study
Carroll S, Gater A, Abetz L, Demuth D, Smith F, Mannan A
Poster session presented at: British Geriatrics Society Autumn Meeting, Brighton, UK, 12–14 October 2011
Burden of herpes zoster and post-herpetic neuralgia: Interim findings from a cross-sectional, patient-reported outcomes study
Carroll S, Gater A, Abetz L, Demuth D, Smith F, Mannan A
Poster session presented at: British Pain Society Annual Scientific Meeting, Edinburgh, Scotland, 21–24 June 2011
Herpes zoster and post-herpetic neuralgia: Considerations for a prospective, cross-sectional, patient reported outcomes study
Carroll S, Gater A, Abetz L, Demuth D, Smith F, Mannan A
Value Health 2010;13:A441
Herpes zoster and post-herpetic neuralgia: Considerations for a prospective, cross-sectional, patient reported outcomes study
Carroll S, Gater A, Abetz L, Demuth D, Smith F, Mannan A
Poster presented at ISPOR 13th Annual European Congress, 6-9 November 2010, Prague, Czech Republic
Impact of MMRV mass vaccination with or without a catch up program on the incidence of varicella complications in France
Ouwens M, Littlewood K, Sauboin C, Tehard B, Alain S, Denis F, Boelle PY
Poster presented at ISPOR 13th Annual European Congress, 6-9 November 2010, Prague, Czech Republic
Quantifying the patient-reported burden of herpes zoster and post-herpetic neuralgia in the UK: practical considerations
Gater A, Carroll S, Abetz L, Demuth D, Smith F, Mannan A
Qual Life Res 2010;19:123